Serial ctDNA evaluation to predict clinical progression in patients with advanced urothelial carcinoma.
Year: 2022
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Kyrillus Samaan Shohdy, Dario Martin Villamar, Yen Cao, Janson Trieu, Kristin Sedgwick Price, Rebecca Nagy, Scott T. Tagawa, Ana M. Molina, Cora N. Sternberg, David M. Nanus, Petros Grivas, Guru P. Sonpavde, Juan Miguel Mosquera, Olivier Elemento, Nicholas J. Vogelzang, Bishoy Morris Faltas
Institutions: The Christie Hospital, The Christie NHS Foundation Trust, University of Chicago, University of Chicago Medicine Comprehensive Cancer Center, University of Nevada, Las Vegas, Guardant (United States), Weill Cornell Medicine, University of Washington, Fred Hutch Cancer Center, Dana-Farber Cancer Institute, NewYork–Presbyterian Hospital, Comprehensive Cancer Centers of Nevada
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
Funder: Conquer Cancer Foundation
OpenAlex ID: W4213168390
